Cardiome Pharma Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported, total revenue of $5,199,000, operating loss of $5,492,000, loss before income taxes of $6,290,000, net loss of $6,333,000, net cash used in operating activities of $6,844,000, purchase of intangible assets of $12,000, compared to total revenue of $7,090,000, operating loss of $1,131,000, loss before income taxes of $1,189,000, net loss of $1,234,000, net cash used in operating activities of $5,216,000, purchase of intangible assets of $15,000, for the same period a year ago.

The company to meet its annual 2017 revenue target of approximately $28 to $30 million. The company believes that 2017 will be a pivotal year.